Paraganglioma
📧 Sign up to get email alerts when something new happens for Paraganglioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Ivonescimab in the Treatment of Multiple Advanced Tumors [Phase 2]
An update indicating Ivonescimab is being studied in a Phase 2 trial for multiple advanced tumors and is currently recruiting. The trial cov…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating cabozantinib S-malate in patients with metastatic or unresectable pheochromocytoma or paraganglioma; results were p…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Using the EHR to Advance Genomic Medicine Across a Diverse Health System [NA]
This update describes a University of Pennsylvania-led trial that uses electronic health records to advance genomic medicine across a divers…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: An International Study on Pediatric Patients With Rare Tumors.
An international pediatric clinical trial study focused on rare tumors is currently recruiting, covering multiple tumor types.
-
CLINICAL_TRIALS research · 2025-06-30Clinical Trial Update: Prognostic's Factors of Head and Neck Paragangliomas Evolution
This clinical trial update from Hospices Civils de Lyon investigates prognostic factors that influence the evolution of head and neck paraga…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study [Phase 2]
Phase 2 CABATEN trial evaluated cabozantinib in combination with atezolizumab for advanced neuroendocrine neoplasms of the endocrine system.…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma [Phase 4]
A Phase 4 trial is evaluating the safety and effects of omitting preoperative alpha-adrenergic blockade in normotensive pheochromocytoma (wi…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: National Study of Adrenal Tumours
An update on a national study of adrenal tumours, currently enrolling by invitation and focusing on pheochromocytoma, paraganglioma, adrenoc…
-
CLINICAL_TRIALS withdrawal · 2025-01-21Clinical Trial Update: 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System [Phase 2]
The Phase 2 trial evaluating the radiopharmaceutical 18F-mFBG for neural crest tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs [Phase 2]
Phase 2 study evaluating safety and dosimetry of Lutathera (lutetium-177 DOTATATE) in adolescent patients with gastroenteropancreatic neuroe…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Hereditary Pheochromocytoma Assessment of Tumour Immunologies
Radboud University Medical Center is sponsoring a clinical trial assessing tumour immunologies in hereditary pheochromocytoma, currently rec…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Correlation Between Preoperative Images of PPGL and Intraoperative Hemodynamics
This clinical trial update analyzes the relationship between preoperative imaging of pheochromocytoma and paraganglioma (PPGL) and intraoper…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma [Phase 2]
Phase 2 trial evaluating Sunitinib in patients with recurrent paraganglioma and pheochromocytoma; the study is completed and results have be…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: "Receptor Radionuclide Therapy With 177Lu-DOTATOC [Phase 2]
A Phase 2 trial evaluating receptor radionuclide therapy with 177Lu-DOTATOC for neuroendocrine tumors, including paraganglioma and pheochrom…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Clinical study from Universidad Nacional Autónoma de México exploring genetic factors underlying neuroendocrine neoplasms. The trial is curr…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma [Phase 2]
Phase 2 trial update showing efficacy and safety data for anlotinib in patients with metastatic pheochromocytoma or paraganglioma.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)
This clinical trial, sponsored by King's College Hospital NHS Trust, studies the incidence and outcomes of metabolically active brown adipos…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers
A clinical trial update describing a study on environmental exposures and tumor risk in SDHx mutation carriers; the trial is not yet recruit…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) [NA]
The MICROBAT trial investigating infrared thermography for detection of brown adipose tissue was terminated, involving patients with pheochr…
-
CLINICAL_TRIALS trial_result · 2023-11-20Clinical Trial Update: Preoperative Alpha Blockade for Pheochromocytoma [Phase 3]
Phase 3 trial evaluating preoperative alpha blockade for pheochromocytoma and paraganglioma has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL [Phase 2]
Phase 2 study evaluating temozolomide as neoadjuvant therapy for pheochromocytoma and paraganglioma.
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL [Phase 2]
Phase 2 trial update evaluating safety and effectiveness of anlotinib as neoadjuvant therapy for pheochromocytoma and paraganglioma.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: The Efficacy and Safety of Temozolomide in Patients With MPPGL [Phase 2]
Phase 2 trial evaluating temozolomide for malignant pheochromocytoma and paraganglioma has completed.